No cross-resistance after sequential use of romiplostim and eltrombopag in chronic immune thrombocytopenic purpura.

D'Arena, Giovanni; Guariglia, Roberto; Mansueto, Giovanna; Martorelli, Maria Carmen; Pietrantuono, Giuseppe; Villani, Oreste; Lerose, Rosa; Musto, Pellegrino

D'Arena, Giovanni; Guariglia, Roberto; Mansueto, Giovanna; Martorelli, Maria Carmen; Pietrantuono, Giuseppe; Villani, Oreste; Lerose, Rosa; Musto, Pellegrino.

Blood ; 121(7): 1240-2, 2013 Feb 14.

Article in En | MEDLINE | ID: mdl-23411736

Subject(s)

Benzoates/administration & dosage; Hydrazines/administration & dosage; Purpura, Thrombocytopenic, Idiopathic/drug therapy; Pyrazoles/administration & dosage; Receptors, Fc/administration & dosage; Recombinant Fusion Proteins/administration & dosage; Thrombopoietin/administration & dosage; Chronic Disease; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Count; Purpura, Thrombocytopenic, Idiopathic/blood; Receptors, Thrombopoietin/agonists; Salvage Therapy; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrazoles / Thrombopoietin / Benzoates / Recombinant Fusion Proteins / Receptors, Fc / Purpura, Thrombocytopenic, Idiopathic / Hydrazines Limits: Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google